The FDA has also approved tirzepatide, under the brand name Zepbound, for treating obesity
A separate JAMA Oncology study by Dai and colleagues (2025) found about 17% lower overall cancer incidence (hazard ratio approximately 0.83) in adults with obesity who used GLP-1 receptor agonists
For $99, this test provides actionable insights to optimize your medication selection and dosing strategy based on your individual biology
Acknowledgments We are grateful to Mary Pragnell, B.A., for language revision and to Maria Luisa Dibenedetto and Alessandro Bergamasco for their precious collaboration
But how severely you feel them, and how dangerous they become, depends a lot on muscle mass, hydration, heat, and diet, which are very Indian-specific issues
Liver X receptors in lipid signalling and membrane homeostasis